“multiple-myeloma” Archives

in
Entry Author Date Location
Restructuring Looms for Forum as Neuro Drug Fails Key Clinical Test 03/24/16 Boston
Phoenix, Baird’s New CEO, & Epic’s Growth: This Week’s WI Watchlist 01/08/16 Wisconsin
East Coast Biotech Roundup: ASH, Kallyope, SQZ, Kyras & More 12/11/15 Boston
Shares in Cellectar Tumble After It Announces $3.3M Stock Offering 09/28/15 Wisconsin
Constellation Pharma Plots IPO Run As Genentech Passes on Buyout Deal 08/24/15 Boston
Celgene, Bluebird Streamline CAR-T Partnership To Fight Myeloma 06/03/15 Boston
ASCO Roundup: Checkpoints, Pushback Against Prices, CAR-T & More 06/02/15 National
East Coast Biotech Roundup: Hemophilia, Levin, Vertex, Semma & More 03/27/15 Boston
Tiger Teams, Dropping Subs, and Biotech’s Elusive Second Strikes 03/03/15 National
East Coast Biotech Roundup: Vertex, Syndax, Build-to-Buy Deals & More 02/20/15 Boston
West Coast Biotech Roundup: Qualcomm, Google X, Mapp, Onyx, & More 01/29/15 San Francisco
Officials Say Fuji’s Purchase of Kalon Boosts Texas’s Biotech Profile 12/22/14 Texas
After Spinning Onyx into Gold, Coles Returns to Lead a CNS Startup 12/15/14 Boston
ASH Roundup: Immunotherapy Stars, Gene Therapy Leaps Ahead 12/11/14 San Francisco
Prescription Drug Pricing: The Fine Line Between Value and Greed 12/02/14 Boston
Wisconsin Roundup: VictorySpark, Imbed, Virent, Cellectar, & More 09/09/14 Wisconsin
John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief 09/07/14 Boston
Military Strategies Being Used in the War on Cancer 08/04/14 Seattle
How a Little Serendipity Led Acceleron to a Crippling Blood Disease 07/17/14 Boston
Amgen Agrees to Buy Onyx for $125 Per Share, or $10.4B 08/25/13 San Francisco
Celgene Partner Acceleron Files For IPO; Plans to Raise Up to $75M 08/07/13 Boston
Dunsire Out at Millennium as Takeda Reorganizes, Cuts Costs 05/09/13 Boston
Celgene Wins FDA Approval of Third Myeloma Drug 02/08/13 New York
East Coast Life Sciences Roundup: Ariad, Celgene, Amgen, More 12/14/12 Boston
Onyx, Millennium, Ariad: Firms to Watch at Hematology Meeting 12/07/12 Boston
GNS to Use Big Data to Fight Multiple Myeloma 11/08/12 Boston
Richard Brewer, Former Scios CEO and Dendreon Chairman, Dies at 61 08/15/12 San Francisco
Onyx Drug Effective in New Myeloma Patients, Taking Aim at Millennium 12/12/11 San Francisco
Epigenetic Drug Startup Tensha Therapeutics Snags $15M Series A 09/12/11 Boston
Seattle Genetics: The Next Litmus Test for High Priced Cancer Drugs 08/22/11 National
Page 1 of 2 next page »